Staphylococcus aureus persisters tolerant to bactericidal antibiotics.
about
Persisters-as elusive as everL-form bacteria, chronic diseases and the origins of lifeGlucose Augments Killing Efficiency of Daptomycin Challenged Staphylococcus aureus PersistersStaphylococcus aureus Small Colony Variants (SCVs): a road map for the metabolic pathways involved in persistent infectionsEffective removal of staphylococcal biofilms by the endolysin LysH5.Characterization of multi-drug tolerant persister cells in Streptococcus suis.Glycerol uptake is important for L-form formation and persistence in Staphylococcus aureus.A new platform for ultra-high density Staphylococcus aureus transposon librariesThe MazEF Toxin-Antitoxin System Alters the β-Lactam Susceptibility of Staphylococcus aureusFusion with a cell wall binding domain renders autolysin LytM a potent anti-Staphylococcus aureus agent.Transposon Mutagenesis Identifies Novel Genes Associated with Staphylococcus aureus Persister FormationA Clinical Drug Library Screen Identifies Tosufloxacin as Being Highly Active against Staphylococcus aureus PersistersAntimicrobial resistance and virulence: a successful or deleterious association in the bacterial world?The Small Colony Variant of Listeria monocytogenes Is More Tolerant to Antibiotics and Has Altered Survival in RAW 264.7 Murine MacrophagesPersister formation in Staphylococcus aureus is associated with ATP depletion.Evaluation of short synthetic antimicrobial peptides for treatment of drug-resistant and intracellular Staphylococcus aureusA point mutation in AgrC determines cytotoxic or colonizing properties associated with phenotypic variants of ST22 MRSA strainsTherapeutic Potential of Gramicidin S in the Treatment of Root Canal Infections.Absence of Protoheme IX Farnesyltransferase CtaB Causes Virulence Attenuation but Enhances Pigment Production and Persister Survival in MRSA.The role of metabolism in bacterial persistenceMetabolic aspects of bacterial persisters.Effects of meropenem exposure in persister cells of Acinetobacter calcoaceticus-baumannii.Bacteriophage Lysin CF-301, a Potent Antistaphylococcal Biofilm Agent.Interactions between Pseudomonas aeruginosa and Staphylococcus aureus during co-cultivations and polymicrobial infections.Nonstable Staphylococcus aureus Small-Colony Variants Are Induced by Low pH and Sensitized to Antimicrobial Therapy by Phagolysosomal Alkalinization.One-stage Revision With Catheter Infusion of Intraarticular Antibiotics Successfully Treats Infected THA.Inhibition of fracture healing in the presence of contamination by Staphylococcus aureus: Effects of growth state and immune response.The identification of Staphylococcus aureus factors required for pathogenicity and growth in human blood.Contribution of the Chromosomal ccdAB Operon to Bacterial Drug Tolerance.Efficient Killing of Planktonic and Biofilm-Embedded Coagulase-Negative Staphylococci by Bactericidal Protein P128.Antimicrobial peptide-inspired NH125 analogues: bacterial and fungal biofilm-eradicating agents and rapid killers of MRSA persisters.A Highly Potent Class of Halogenated Phenazine Antibacterial and Biofilm-Eradicating Agents Accessed Through a Modular Wohl-Aue Synthesis.Characterization of blue light irradiation effects on pathogenic and nonpathogenic Escherichia coli.Cystic Fibrosis Isolates of Pseudomonas aeruginosa Retain Iron-Regulated Antimicrobial Activity against Staphylococcus aureus through the Action of Multiple Alkylquinolones.Daptomycin Tolerance in the Staphylococcus aureus pitA6 Mutant Is Due to Upregulation of the dlt Operon.Phenotypic Modifications in Staphylococcus aureus Cells Exposed to High Concentrations of Vancomycin and Teicoplanin.Antibiotic regimen based on population analysis of residing persister cells eradicates Staphylococcus epidermidis biofilms.Non-Monotonic Survival of Staphylococcus aureus with Respect to Ciprofloxacin Concentration Arises from Prophage-Dependent Killing of Persisters.Halogenated Phenazines that Potently Eradicate Biofilms, MRSA Persister Cells in Non-Biofilm Cultures, and Mycobacterium tuberculosis.Genotype by random environmental interactions gives an advantage to non-favored minor alleles.
P2860
Q26748708-E1F1A2F3-5550-4454-95AD-7A0FE89C28B0Q28073545-1B854945-65CF-42AA-BCF1-B4FF0B3FE39FQ28550612-9C333187-1E2F-4B02-A958-B78A3D350352Q33958329-D7C8B164-5C16-4D64-A174-529E84F595D3Q34156197-2AC6092B-B1E1-43EF-9AA7-AAB8894985D0Q35178525-A3436A4A-5AEA-45CB-B034-8926002C12A6Q35274135-FFB120B6-7598-4C64-A22D-977A3C71F301Q35319419-E5838B22-EFD8-43EA-BEE0-D3CD0548AA98Q35597691-F2EB334C-157A-438F-B66C-B3F42470A110Q35653429-4E7C0F6E-D708-4B6E-94A1-FC4A19487CDFQ35896659-C02FFE9B-C421-44A4-9DE1-69CEC71E4AFBQ35973164-27E240A8-1790-4AF9-8E54-A348CCC6AA44Q36757725-D5B4977A-DF25-4556-BCC4-3F289B4E2359Q37063545-3E9BE905-E52F-4B9C-B0E3-EA9382821C90Q37064997-40286FD5-843F-4481-AF03-511BB60583ABQ37089144-70B265BF-CE59-4F9C-8BF4-D3571D9184CDQ37166976-25D8AFDA-B8AE-4463-8BE9-021103778A23Q37290856-A7F2CCBA-2B37-43AB-BC1E-373FB6698080Q37360993-C34DE04C-EBC4-4F84-B52E-E97E2DEEBB2FQ38195596-450373E5-884D-4829-99C4-F50B1B550E32Q38265559-5FE5F6A8-BF7B-4A95-8AA3-B114B279B8EAQ38767143-4C17B44E-6ED8-4649-8437-3B207CEC9EEBQ38810296-3DD6F832-96D1-4A33-84AB-2EFE97065472Q38847303-C6B148A5-0649-4F82-B916-2AC014130584Q38851656-B43A439B-CD4A-4306-A35E-0A1153E7F24CQ38924258-481476DF-49BA-4CFF-B40D-05F7925BF1CCQ39226629-B439A461-A1FF-4AFA-B284-5932E2602904Q40093376-69EAB578-3B7C-4D38-853B-94005E181092Q40148460-364917D8-9D2C-4EB3-B27D-954EBE84E5F9Q40192368-75365CC4-CBFC-4DC0-84EE-4089DF09BEB7Q40202244-91C7B55A-A283-4C69-BD81-EF88528F73C3Q40208622-1268C452-5D6B-4FB8-BA82-501FDE1AC81EQ40282417-C8CFB20F-14A7-4A22-B4E8-866405BC7FE8Q40580336-D62B9615-6FC3-4B6E-BF4A-D661740A2363Q40789016-36C6C73C-70BC-442C-981D-218253684947Q40809099-862B5F08-CB12-461A-A024-FA54918CF3D8Q40864225-9CADA681-9C16-4648-A9DC-9B603ED24073Q40900218-18A822A2-AE48-4DD3-902F-D1552EAC3B57Q40946232-10DF055D-D878-482B-B921-2D54A8975EBDQ40998566-896C535C-BC62-4C25-8EB0-486FB8D4A7AC
P2860
Staphylococcus aureus persisters tolerant to bactericidal antibiotics.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Staphylococcus aureus persisters tolerant to bactericidal antibiotics.
@en
Staphylococcus aureus persisters tolerant to bactericidal antibiotics.
@nl
type
label
Staphylococcus aureus persisters tolerant to bactericidal antibiotics.
@en
Staphylococcus aureus persisters tolerant to bactericidal antibiotics.
@nl
prefLabel
Staphylococcus aureus persisters tolerant to bactericidal antibiotics.
@en
Staphylococcus aureus persisters tolerant to bactericidal antibiotics.
@nl
P2093
P2860
P356
P1476
Staphylococcus aureus persisters tolerant to bactericidal antibiotics.
@en
P2093
Ralph Bertram
Sabrina Lechner
P2860
P304
P356
10.1159/000342449
P577
2012-09-14T00:00:00Z